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Abstract 
Introduction:  Physician-assisted suicide (PAS) is an end of life (EOL) option that involves a 
patient ingesting a lethal medication that has been prescribed by a physician after a complex 
vetting process.  In certain countries and the United States (US) where PAS is legal, patients 
avoid EOL suffering and may have more control over the dying process.   
Scholarly Inquiry Question: Do patients who seek end-of-life care by means of PAS have a 
greater sense of control of their dying process versus those patients who do not or are not 
allowed to participate in PAS?  
Supporting Evidence:  Physical and emotional suffering are significant motivators for terminally 
ill patients to desire PAS (Nissim et al., 2009; Johansen et al., 2005; Maessen et al., 2009; Regan 
et al.).  Through PAS, patients are also able to control the circumstances of their death, including 
the time of death, location, rituals, and individuals present (Maessen et al., 2009; Smith et al., 
2011).  Healthcare providers play a critical role in treating terminally-ill patients and upholding 
patient autonomy; non-judgmental and timely communication are the foundation for discussing 
PAS (Georges et al., 2007; Pasman et al., 2013).  Suffering while dying is subjective (Dees et al., 
2010); PAS is an EOL option that upholds the ethical principle of autonomy(Nissim et al., 2009). 
Theory and Conceptual Framework:  The Theory of Relational Autonomy was used to guide this 
integrative literature review.  The goal of this theory is to build social relationships and 
institutions that encourage individuals to lead self-governing lives (Mackenzie, 2015).   
Conclusions: Terminal illness is life-altering.  PAS contributes to a better quality of death and 
upholds patient autonomy by allowing the patient to die on their own terms: deciding who is 
present, where and when their death will take place, and ultimately ending the process of painful 
and undignified lingering. 
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Introduction 
In 1994, Oregon was the first state in the United States to legalize physician-assisted 
suicide (PAS) for terminally ill adults with a voter-supported initiative called the Death With 
Dignity Act (Volker, 2007).  The 2018 annual report from the Oregon Health Authority (OHA) 
has been summarized by the organization Death with Dignity (DWD); this report revealed that 
168 people in Oregon used lethal medications obtained under the law in 2018, with a death rate 
of 49.5 of 10,000 deaths.  Of the people who participated in physician-assisted suicide, the 
majority had cancer (62.5%), were actively in hospice care (90.5%), and died at home (88.6%).  
With regard to end-of-life concerns motivating them to participate in PAS, patients reported the 
loss of autonomy (91.7%), decreased capability to be involved in activities that made life 
enjoyable (90.5%), and loss of dignity (66.7%) were prime factors (DWD, 2019).  Oregon will 
be referenced frequently throughout this paper; it is considered the “laboratory” of the U.S. with 
regard physician-assisted suicide legislation (Volker, 2007).   
In 1997, the Supreme Court of the United States ruled that each state may independently 
decide to legalize physician-assisted suicide (Volker, 2007).  Since this ruling, several other 
states have chosen to pass legislation similar to Oregon’s Death with Dignity Act; in June 2019, 
Maine became the eighth state to legalize PAS (Villenueve, 2019).  With 18 states also 
considering PAS (Villenueve, 2019), the discussion surrounding physician-assisted suicide is 
acutely relevant to the medical community in the United States.  Despite the possible discomfort 
surrounding a medical option that shortens rather than prolongs life, understanding and forming 
an opinion about PAS is vital for healthcare providers who participate in conversations with their 
patients about end-of-life options. 
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Background 
Physician-assisted suicide (PAS) is defined as the use of a lethal prescription medication 
from a licensed physician that is ingested by the patient on their own power with the intent of 
ending their life (Shibata, 2017).  PAS differs from euthanasia for which euthanasia is defined as 
an event when a medication is administered by a third party with the intention of ending the 
person’s life at his or her request (Chapple, Ziebland, McPherson, & Herxheimer, 2006).  Some 
studies use “aid-in-dying” as an umbrella term for both PAS and euthanasia; aid-in-dying is also 
used to simply reference the act of the medical community assisting in shortening the life of the 
patient. 
Using Oregon as an example, patients who are interested in PAS must meet specific 
criteria, according to the Physician Aid-in-Dying Clinical Committee and Oregon Death with 
Dignity Act of 1994, Chapter 127.  Per the Act, the patient must be over the age of 18, show 
proof of residency in the State of Oregon (via a driver’s license, lease agreement, tax return, or 
voter registration), be capable of making major medical decisions as determined by their 
physician, and have a terminal diagnosis or a type of medical condition for which the outcome 
would be death within six months or less (1994).  Capable is defined as “in the opinion of a court 
or in the opinion of the patient’s healthcare provider or consulting physician, psychiatrist or 
psychologist, a patient has the ability to make and communicate health care decisions to health 
care providers, including communication through persons familiar with the patient’s manner of 
communicating if those persons are available” (Oregon Death with Dignity Act, 1994, p. 1).  
Healthcare provider (HCP) will be used to include any physician or advanced practice provider 
primarily caring for the patient during end of life.   
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Upon a patient’s request for PAS, the healthcare provider is required to ask questions to 
assess for any physical, psychological, financial, social, and spiritual issues that could be 
influencing the patient’s request.  The goals of the initial assessment by the HCP are to prevent 
premature action by the patient, ensure the patient is making the request free from external 
pressure, and to make certain that the patient is considering or has considered alternatives to 
PAS.  The decision to participate in PAS must be voluntary and intentional, meaning the patient 
understands that their participation of such acts will result in the ending of their life.  If the 
healthcare provider is concerned for the presence of mental health conditions influencing the 
patient’s decision, the physician shall refer the patient to a licensed psychiatrist for a thorough 
evaluation (Oregon Death with Dignity Act, 1994; Orentlicher, Pope, & Rich, 2016).   
According to the Oregon Death with Dignity Act, the attending physician is the primary 
physician (healthcare provider) who is caring for and treating the patient’s terminal illness 
(1994).  The HCP is not required to obtain a special license to prescribe lethal medications for 
PAS. Should a patient request PAS, the healthcare provider has the right to refuse to participate 
in such events.  If the primary healthcare provider declines to be involved in PAS, the patient’s 
care and medical records would be transferred to a new healthcare provider who provides 
services associated with PAS (Oregon Death with Dignity Act, 1994).  When patients are seen 
and evaluated by a healthcare provide, this evaluation serves as clearance for the patient to make 
this type of serious decision.  Thus, healthcare providers are participating in good-faith 
compliance with Oregon’s Death with Dignity Act, and they are protected from any criminal 
liability or professional disciplinary action (1994).   
As with other major medical procedures, the healthcare provider must establish informed 
consent.   This is accomplished by the healthcare provider making the patient aware of other end-
Autonomy and Physician-Assisted Suicide 7 
of-life options such as hospice care, aggressive symptom management, the voluntary cessation of 
oral intake, discontinuing life-sustaining treatment, and palliative sedation (Oregon Death with 
Dignity Act, 1994; Orentlicher et al., 2016).  The healthcare provider must also inform the 
patient that the lethal prescription medication will almost certainly cause death; the medication 
potentially induces vomiting, which can, rarely, result in failure to cause death; the patient can 
refuse PAS at any time; the HCP will care for the patient regardless of the patient’s decision to 
participate in PAS; and the patient must be physically able to ingest the medication 
independently or inject the medication in their feeding tube.  Family may only help the patient by 
mixing the medication in a cup but are not allowed to administer the lethal dose of medication.  
The healthcare provider must document the patient’s understanding of each item to show proof 
of informed consent (Oregon Death with Dignity Act, 1994; Orentlicher et al., 2016).   
The healthcare provider is required to refer the patient to a consulting healthcare provider 
who is qualified by specialty or experience to assess the patient and make both a prognosis and 
diagnosis about the patient’s disease.  “A consulting physician shall examine the patient and his 
or her relevant medical records and confirm, in writing, the [healthcare provider’s] diagnosis that 
the patient is suffering from a terminal disease, and verify that the patient is capable, is acting 
voluntarily and has made an informed decision” (Oregon Death with Dignity Act, 1994, p. 4). 
Continuing to use Oregon as a model, the patient must make two verbal requests for PAS 
to their healthcare provider, at least fifteen days apart (Orentlicher et al., 2016; Volker, 2007).  
The patient must also present a written request (see Appendix), witnessed by two individuals 
who sign the request for PAS form in the presence of the patient and attest to the patient acting 
voluntarily, having the mental capacity, and not being coerced into signing the request for PAS 
(Oregon Death with Dignity Act, 1994).  The witnesses cannot be a relative, a financial 
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beneficiary, the healthcare provider, or a staff member of the institution where the patient is 
receiving care (Oregon Death with Dignity Act, 1994).  Encouraging the patient to include his or 
her family in the decision-making process is recommended but not required (Oregon Death with 
Dignity Act, 1994).  If the patient qualifies for PAS, the healthcare provider writes the 
prescription for the lethal medication, which is then dispensed by a pharmacist or the healthcare 
provider (Volker, 2007).  
 In Oregon, over one-third of patients who receive a lethal prescription choose not to 
ingest the medication, for reasons that are not documented (Orentlicher et al., 2016).  A literature 
search performed by Willem, Groenewoud, and van der Wal looked at the various medications 
used in physician-assisted death, which includes PAS and euthanasia (1999). This study found 
that over forty medications had been used in physician-assisted death.  Most of the literature in 
this study came from the Netherlands, and the medication regimen for PAS varied across HCPs 
and institutions.  Thirty percent of patients received one medication, either an opioid or 
barbiturate; 57% received two medications, typically a barbiturate or a benzodiazepine with a 
neuromuscular relaxant.  Other medications that have been utilized include propofol, ketamine, 
insulin, and potassium.  However, the recommendation for PAS is 9g of a short-acting 
barbiturate, either secobarbital or pentobarbital, which is what has been used in the United States 
(Orentlicher et al., 2016; Willem, Groenewoud, & van der Wal, 1999).   
In physician-assisted suicide, the patient must take the medication independently.  The 
ingestion process starts with the administration of an anti-emetic such as Reglan 
(metoproclamide) or Zofran (ondansetron) to prevent nausea.  About an hour later, the patient 
mixes eight ounces of water with the barbiturate.  The patient then must ingest the entire mixture 
quickly to prevent falling asleep and risk not getting the full dose of the medication; the patient 
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goes into a comatose state which leads to respiratory suppression with the end result of death.   
In Oregon and Washington State, the healthcare provider cites “respiratory failure” as the cause 
of death on the death certificate to maintain patient confidentiality (Orentlicher et al., 2016). 
The Netherlands is seen as the global leader in setting the precedent for physician-
assisted suicide and euthanasia.  According to Rietjens, van der Maas, Onwuteaka-Philipsen, van 
Delden, and van der Heide, the history of aid-in-dying in the Netherlands began in 1973, when a 
physician’s mother repeatedly requested assistance in dying following a debilitating stroke 
(2009).  The physician chose to help her mother die via lethal medication; the physician was 
subsequently prosecuted and found guilty of committing murder.  This case initiated the 
conversation about the medical community’s conflicting role in relieving suffering while doing 
no harm (Rietjens, van der Maas, Onwuteaka-Philipsen, van Delden, & van der Heide, 2009).  
Physician-assisted suicide and euthanasia were regularly practiced in the Netherlands throughout 
the 1980s and 1990s, but the fear of prosecution caused an absence of transparency from the 
medical community regarding end-of-life treatment.  Each reported case was scrutinized closely, 
and the court decided whether to prosecute the healthcare provider.  The Euthanasia Act was 
passed in 2002 to officially legalize the practice of aid-in-dying and protect healthcare providers, 
but mainly legalized an existing practice.  Since passing The Euthanasia Act in 2002, most 
healthcare providers in the Netherlands report an increase in legal certainty and care in the dying 
patient (Rietjens et al., 2009).   
Physician-assisted suicide is also legal in Switzerland, Belgium, and Canada (Hurst, 
Zellweger, Bosshard, & Bopp, 2018).  In Switzerland, assisted suicide has been legal since 1918, 
if altruism is the motivation for helping someone end their own life (Hurst & Mauron, 2003).  In 
Canada, PAS was legalized in 2015 following the British Columbia Supreme Court Case, Carter 
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vs Canada, in which two terminally ill women were granted the right to end their own lives 
(Supreme Court of Canada, 2016).  Like the Netherlands, aid-in-dying was regularly practiced 
and considered a patient’s right in Belgium decades before it was formally legalized in 2002 
(Saad, 2017).  In the United States, PAS is legal in Oregon, Maine, Vermont, Washington, 
Montana, California, Washington D.C., and Bernalillo County in New Mexico (Shibata, 2017; 
DWD, 2019).   
The criteria to qualify for PAS in both the Netherlands and Belgium are similar to 
Oregon, except the healthcare provider must also believe the patient is suffering unbearably and 
hopelessly (Pasman, Willems, Onwuteaka-Philipsen, 2013).   Suffering as a motivation to 
participate in aid-in-dying is frequently cited in the data surrounding end-of-life decision-
making.  An integrative review by Dees, Vermooij-Dassen, Dekkers, and van Weel concluded 
that a true definition of patient suffering in the context of a request for PAS or euthanasia does 
not exist due to its subjectivity (2010).  For the purposes of this paper, their conceptual definition 
of suffering will be used:  “Unbearable suffering in the context of a request for euthanasia or 
physician-assisted suicide is a profoundly personal experience of an actual or perceived 
impending threat to the integrity or life of the person, which has a significant duration and a 
central place in the person’s mind” (Dees, Vernooij-Dassen, Dekkers, & van Wheel, p. 350, 
2010).  While family members and medical professionals may also undergo suffering, this paper 
will focus on the patient experience up until death. 
During the dying process, suffering and relief from suffering vary between different 
terminal illnesses, as do the motivations for desiring a hastened death.  Pierson, Curtis, and 
Patrick found that patients dying from AIDS longed for a “good death,” wanting complete pain 
control, avoiding prolonged dying via life support, and desiring intact bodily functions (2002).  
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Patients with amyotrophic lateral sclerosis (ALS) in the Netherlands feared choking to death as 
their bodies slowly lost control of basic, involuntary functions (Maessen et al., 2009).  After 
witnessing their loved ones deteriorate and die from the same genetic disease, individuals in the 
early stages of Huntington’s disease also feared suffering through losing physical function and a 
sense of self (Regan et al., 2017).  Patients with advanced cancer viewed the option of hastening 
death in the future as reassuring for the present, allowing them to imagine a sense of control and 
autonomy (Nissim, Gagliese, & Rodin, 2009).   
Upholding the ethical principle of autonomy is a frequently cited reason for ensuring 
access to physician-assisted suicide.  In Principles of Biomedical Ethics, Beauchamp and 
Childress define personal autonomy as “self-rule that is free from both controlling interference 
by others and from limitations, such as inadequate understanding, that prevent meaningful 
choice” (p. 58, 2001).  In medicine, the right to autonomy has been used by competent patients to 
refuse or request treatment (Shibata, 2017).  Personal autonomy is often referenced with regard 
to physician-assisted suicide, because limiting a patient’s ability to choose aid-in-dying is forcing 
the patient to participate in a dying process that is usually filled with pain and suffering.  
Denying anyone relief from this type of suffering could be considered violation of the patient’s  
ethical principle of autonomy (Shibata, 2017).  PAS is illegal in most states and countries around 
the world, severely limiting patient’s access to this end-of-life options.  Some patients do travel 
in order to participate in physician-assisted suicide in places where it is legal.  However, in a 
qualitative study exploring Huntington’s disease, participants in the United Kingdom report the 
mutually conflicting conditions of being healthy enough to go to Switzerland but ill enough to 
meet the criteria to qualify for PAS, in addition to difficulties of needing the money to travel and 
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dying in a strange country without a large number of friends or family present (Regan, Preston, 
Eccles, & Simpson, 2017).      
As modern medicine evolves, discussing end-of-life options such as physician-assisted 
suicide become increasingly relevant.  Some may consider PAS to be healthcare providers 
“playing God;” however, with medical marvels such as chemotherapy, intubation and ventilator 
support, feeding tubes, antibiotics, and vasopressors, life is being extended beyond its previous 
natural endpoint.  In addition to focusing on keeping people alive, the medical community must 
also ask the uncomfortable questions about their role in helping patients die with dignity and 
respect.  
Purpose 
The purpose of this scholarly inquiry paper is to explore the patient-experience 
surrounding physician-assisted suicide, particularly with regard to the ethical principle of 
autonomy.  A large body of research has been performed on the moral dilemma nurses and 
healthcare providers face surrounding PAS, focusing on the healthcare professionals rather than 
the patient.  As PAS continues to be introduced to state legislatures across the United States, 
misinformation and moral outrage also eclipse the patient perspective.  In keeping with the 
practice of medicine, the patient’s end-of-life wishes and experience should drive the discussion 
surrounding physician-assisted suicide.   
Scholarly Inquiry Question 
To guide the literature search for this topic, a clinical question was developed using the 
Population (P), Intervention (I), Control (C), Outcome (O), PICO, method. The clinical question 
is as follows: Do patients who seek end-of-life care by means of PAS have a greater sense of 
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control of their dying process versus those patients who do not or are not allowed to participate 
in PAS?  
Method Used for Inquiry 
A traditional, or narrative, literature review was the method used to guide this inquiry; 
this type of review is used to synthesize and summarize a large volume of data on a specific topic 
(Cronin, Ryan, & Coughlan, 2008).   The purpose of a traditional literature review is to not only 
provide a thorough background on a specific subject but also reveal areas requiring further 
research (2008).  The steps to writing this type of literature review include selecting a review 
topic, searching the literature, analyzing and synthesizing the literature, and writing the review 
(2008).  Following the completion of this paper, the interpretations of the literature review will 
provide further recommendations and will be presented to faculty at Winona State University in 
April, 2020.     
Literature Review 
Database Search 
A literature search was conducted through CINAHL/Ebsco World Host and The 
Cochrane Library (Table 1) using the following key words: Patient experience, physician-
assisted suicide, quality of life, and quality of death.  Data was limited to publication between the 
years 2000 and 2019.  Excluded sources include those articles that were not in English language, 
duplicates of previously found articles, or articles in which physician-assisted suicide or 
euthanasia occurred in the event of diseases which were not terminal (i.e. Alzheimer’s disease, 
dementia, or chronic mental illness).  Articles from the perspective of healthcare professionals 
such as nurses or healthcare providers were excluded, and those from the perspective of the 
patient or the patient’s proxies were included.  Articles from proxies were included only if the 
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researcher was examining the patient’s dying experience from the perspective of the patient 
proxies.  Excluded were articles with low levels of evidence, specifically those based on expert 
opinion or discussions of the legal and ethical dilemmas facing providers participating in 
physician-assisted suicide as they are not relevant to the patient experience of PAS.  Of the 
remaining articles, 37 were reviewed, and 13 were included due to their quality, relativity to the 
patient perspective on the use of physician assisted suicide, and diversity of data from the United 
States and countries in Europe. 
Review of the Literature 
 Thirteen articles were reviewed, in-depth (Table 2), and the information has been 
organized by themes.  Each heading within this section will reference a theme, and the evidence 
from the included studies will be synthesized accordingly.  Of note, the data is limited by two 
factors: 1) Due to the nature of the topic, the patient is unable to be interviewed about his or her 
experience posthumously and 2) Studying physician-assisted suicide is restricted to the few 
countries and states where it has been made legal; thus, the evidence is limited to specific 
cultures, religions, and geographic areas.  The results may not be generalizable. 
 Some of the articles from countries where both PAS and euthanasia are legal do not 
differentiate between the two practices.  In addition, participants in the study performed by 
Pierson et al. have a terminal diagnosis of AIDS.  This study was published in 2002; medical 
advancements over the last eighteen years have remarkably improved outcomes for patients 
living with HIV/AIDS.  Though dying of AIDS is unlikely in 2020, the results of the patients’ 
dying experience in this qualitative study are still relevant to this paper. 
Themes from the Literature 
 Patient motivations for participating in physician-assisted suicide. 
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  Physical suffering. 
 Avoiding physical suffering was a frequent motivation for patients with terminal illnesses 
who desired a hastened death.  This section will be divided by disease process.   
 Patients with neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and 
Huntington’s disease primarily experience physical suffering related to loss of voluntary and 
involuntary muscle functioning.  Patients in the early stages of Huntington’s disease reported 
witnessing close relatives die slowly, which caused them to view participating in PAS for 
themselves as an imperfect but necessary solution until a cure is found.  They describe the 
process as being “locked in,” existing but unable to speak, eat, or do anything for one’s self 
(Regan et al., 2017).  “They have in no way been able to sustain her quality of life.  And, as a 
result I don’t see it as a triumph that she is still breathing” (Regan et al, p. 711, 2017).   
 Maessen et al. found that the most common physical reason (70%) for ALS patients to 
participate in PAS was a fear of choking.  Pain was not cited as a reason for hastening death 
(2009); however, in a study measuring patient interest in PAS as reported to the caregiver, 
Ganzini, Silveira, and Johnston found that choking episodes and severity were not significant 
motivations, rather severe insomnia, frequent pain, and discomfort other than pain as statistically 
significant motivations for discussing PAS (2002).  A limitation to the study by Ganzini et al. is 
the accuracy of the caregivers’ reports of the patients’ interest (2002); thus, choking in patients 
with ALS is still considered a physical motivation for participating in PAS. 
 Patients with a terminal cancer diagnosis describe fear of future pain and experiences 
with present or past pain as motivations for participating in aid-in-dying.  During a study 
exploring the attitudes of dying cancer patients toward euthanasia or PAS, Johansen, Hølen, 
Kaasa, Loge, and Materstvedt found that patients had a significant fear of pain, and previous 
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exposure to pain caused a fear of future pain (2005).  “It is the pain that I am most afraid of… 
My only hope is to have no pain” (Johansen, Hølen, Kaasa, Loge, & Materstvedt, p. 456, 2005).  
A longitudinal study of patients with advanced lung and gastrointestinal cancers found that 89% 
of participants contemplated hastening death through PAS or euthanasia as a future exit plan 
based on fears of experiencing severe pain during the final dying phase (Nissim et al., 2009).   
When pain is severe, it consumes all of the attention of the patient (Johansen et al., 2005), 
leaving the patient unable to focus on anything but the pain (Nissim et al., 2009).   A desire for 
PAS would surface, as death is preferable to a prolonged state of severe pain (Johansen et al., 
2005; Nissim et al., 2009).  However, when the pain was alleviated, the motivation for a 
hastened death would diminish (Johansen et al., 2005).  Thus, desire to participate in PAS could 
fluctuate with the patient’s pain level.  “[When the pain is alleviated] then I want to live a little 
bit longer” (Johansen et al., p. 457, 2005).  Severe pain also triggered the patients’ feelings of 
despair (Nissim et al., 2009; Johansen et al., 2005).   
Only one study in this review of literature focused on patients dying from AIDS, a 
qualitative study exploring patients’ perceptions of a good death.  Severity of pain was correlated 
to the degree of the patient experiencing a “bad” death, and absence of pain was the most 
commonly mentioned factor identifying a “good” death.  None of the patients were indifferent to 
the domain of symptom control.  Several of the participants mentioned physician-assisted suicide 
as a method of escaping unbearable pain and ensuring a “good death” (Pierson, Curtis, & Patrick, 
2002).  “There’s no point in keeping people in pain, or so doped up that they’re not aware of 
anything, because that’s the only way you can keep them from being in pain, you know, alive, 
just to be alive.  That’s not living” (Pierson et al., p. 594, 2002). 
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Dees et al. performed a systematic review to create an overview of descriptions of 
unbearable suffering in the context of a request for euthanasia or physician-assisted suicide.  The 
55 articles included in the review showed that physical suffering from the patient’s perspective 
included pain, weakness, and functional impairment as motivations to request aid-in-dying.  
These experiences are inevitable during the terminal phase of an illness, and the irreversible 
disintegration seemed to be the start of openly considering death as preferable to life (2010).  
These motivations are consistent with the findings from Georges et al. who performed a 
retrospective study into the history of the wishes of terminally-ill patients for aid-in-dying by 
interviewing the relatives closest to the patient.  The two most commonly cited physical reasons 
were pain (42%) and dyspnea (26%) (2007).   
Physical suffering in the terminal phase of illness is unavoidable, regardless of illness.   
This evidence reveals that physical suffering is a key motivator for patients to participate in 
physician-assisted suicide.  While aggressive symptom control and palliative care are strategies 
to relieve patients’ distress, suffering in the face of death could be prolonged and persist until the 
end of the patient’s life. 
Emotional suffering. 
In addition to physical suffering, emotional suffering during the terminal phase of illness 
is complex, with multiple layers including anticipating death, becoming dependent on others, and 
feelings of hopelessness or despair.  This section will also be separated according to disease 
process when applicable. 
Ganzini, Silveira, and Johnston performed two studies in Oregon on the same patients with ALS, 
both studies measuring patients’ motivations for aid-in-dying.  The second study was performed 
posthumously, asking patients’ relatives if the patient expressed interest in physician-assisted 
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suicide in the last month of illness.  The second study found that 67% of patients who discussed 
wanting PAS in the last month of life had hopelessness scores of >9 on the Beck Hopelessness 
Scale during the first study (Figure 1).  Only 12% of patients who did not report an interest in 
PAS in the last month of life had elevated hopelessness scores.  Major depressive disorder did 
not predict a desire to participate in PAS (2002). 
Figure 1. Beck Hopelessness Scale 
 
Figure 1. A 20 point questionnaire to assess hopelessness and suicidality in vulnerable 
populations.  Adapted from “Risk to self in psychiatry: Do suicide/self-harm scales help 
clinicians?” by A. Mitchell, 2008, a lecture conducted at the Annual General Meeting of 
the Royal College of Physicians, London.  
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Several years later in the Netherlands, Maessen et al. had similar results when 
researching ALS patients.  Hopelessness was strongly associated with the decision to seek PAS 
or euthanasia (p = 0.04), and no significant association existed between a diagnosis of depression 
or depressive symptoms and euthanasia or PAS (2009).  This suggests that hopelessness, and not 
depression, is a motivator and predictor of patients desiring to participate in physician-assisted 
suicide during the final stages of ALS.   
Other significant motivators to participate in PAS found by Maessen et al. included that 
the patient knew there was no chance of improvement, loss of dignity, and feeling dependent on 
others, though feeling to be a burden on family or friends was not reported frequently (2009).  
Similarly, patients with Huntington’s disease also contributed emotional suffering as a reason for 
PAS, describing  as a loss of self, explaining a fear of entering a persistent vegetative state, 
losing not only complete physical functioning, but also one’s role, personality, meaning, and 
community (Regan et al., 2017). 
 Nissim et al. found that all advanced cancer patients in the study experienced despair and 
contemplated death as an escape.  Many believed that hastening death was the only action that 
would relieve strong feelings of despair, helplessness, and panic (2009).  Future worries such as 
pain, eventually losing hope, and potentially entering a persistent vegetative state influenced 
cancer patients’ wishes for PAS (Johansen et al., 2005).  Patients feel trapped by their disease 
state, “I don’t want to wake up and face this… honestly I just pray that I would just die in my 
sleep” (Nissim et al., p. 168, 2009).     
 When researching the relatives’ perspective on patients who died using euthanasia or 
PAS, Georges et al. found loss of dignity to be the most expressed reason for patients to request 
aid in dying (60%) (2007).  Activities of daily living (ADL) dependency is also a significant 
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motivator, along with the feelings of being a burden and hopelessness (Georges et al., 2007; 
Dees et al., 2010).  Dees et al. details the feelings of existential loss: independence, occupational 
role, sexual desire, and personal status as significant emotional burdens driving patients to 
participate in PAS (2010).   
 While many end-of-life options are focused on controlling physical suffering, these 
studies reveal the immense emotional suffering experienced by individuals with terminal 
illnesses.  Physical suffering and emotional suffering are also linked; pain can influence feelings 
of despair and hopelessness (Johansen et al., 2005; Nissim et al., 2009).  Emotional suffering in 
many forms is a significant motivator for patients to participate in physician-assisted suicide. 
 Economic Motivations in the United States. 
 The United States does not have a state-financed healthcare option for all residents, 
potentially leading patients to desire physician-assisted suicide to avoid accumulating additional 
illness-related bills.  Emanuel, Fairclough, Slutsman, and Emanuel explored the economic 
burden of terminal illness in the United States (2000).  This study found a strong association 
between economic burden and patients with substantial needs in four areas: transportation, 
nursing care, homemaking, and personal care.  Patients with substantial care needs were 
significantly more likely to report that their care was a moderate or great economic hardship for 
their family compared to patients with low care needs.  In families of patients with substantial 
care needs, 10% of the household income was spent on healthcare costs other than their 
insurance premiums, and they or their family had to sell assets, take out a loan, or get an 
additional job  to pay for the patient’s healthcare.  14.9% of these patients had thought about or 
expressed a desire for PAS compared with 8.2% of patients with low care needs (Emanuel, 
Fairclough, Slutsman, & Emanuel, 2000).   
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 Quality of Life and Quality of Death. 
 In harmony with avoiding suffering as a motivation to participate in PAS, physician-
assisted suicide could be an end-of-life option that can influence the patient’s quality end-of-life 
and quality of death.  92% of relatives of patients who died using euthanasia or physician-
assisted suicide in the Netherlands believed that assisted dying had increased the patient’s quality 
end-of-life, and 100% of relatives reported that the patients were ready to die (Georges et al., 
2007).   
 Quality of Life. 
 Access to PAS is instrumental in promoting quality of life in patients with terminal 
illness.  Knowing that physician-assisted suicide is an option allows patients with terminal illness 
to tolerate the present suffering (Nissim et al., 2009).   
 As a disease progresses, patient’s quality of life changes and compels many to desire 
physician-assisted suicide.  Dees et al. gives the example of a formerly athletic and energetic 62-
year-old woman who requested PAS after being diagnosed with metastatic ovarian cancer and 
was facing physical frailty and regular hospitalizations (2010).  Severe pain also significantly 
effects patients’ quality of life in the terminal phase of illness (Dees et al., 2010; Johansen et al., 
2005; Nissim et al., 2009; Pierson et al., 2002).  Patients who are refused access to PAS state that 
they continue to desire death because of a poor quality of life, such as being physically unable to 
do activities of enjoyment  but are limited to sitting around and watching television (Pasma et al., 
2013).   
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Patients can anticipate life changes due to the disease, even if in earlier stages of the 
disease process. These life changes can include physical changes including pain, cosmetic 
changes, side effects of medications; emotional changes due to the distress of the disease burden 
and treatment options; and overall a different perspective of their life after being diagnosed with 
such an illness.  Patients with Huntington’s disease report knowing that they would not be able to 
maintain their quality of life due to the impending disease progression, which caused them to 
embrace assisted dying when the time came (Regan et al., 2017).  These same patients reported 
that their diagnosis also forced them to be intentional with their time and actions prior to their 
death (2017).   
 Quality of Death. 
 Physician-assisted suicide can play a lead role in creating better quality of death.  
Participants with advanced cancer perceived PAS as an option to avoid painful and undignified 
lingering, which would in turn cause their family to linger with them (Nissim et al., 2009).  
“Suicide is a way of exiting.  I don’t want to talk about that because I like life, and I have lots to 
live for, but if I come to the point when I am too weak to do anything, then I don’t want to stay” 
(Nissim et al., p. 168, 2009).  Patients with AIDS experienced similar feelings, concerned that 
dying would inevitably include a long, drawn out process; physician-assisted suicide would 
allow them to avoid that process, creating a ‘good’ death experience (Pierson et al., 2002).  This 
belief is echoed in patients with Huntington’s disease, believing that assisted dying embodies an 
act of kindness (Regan et al., 2017).  “Nan was just a vegetable by the end of it, bless her, she 
was literally just a case.  There was nothing left inside.  We were keeping her alive, but what for?  
She wasn’t getting any joy out of life” (Regan et al., p. 711, 2017).  Thirty-three percent of 
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patients in a study by Nissim et al. believed that physician-assisted suicide and euthanasia are 
part of the medical community’s duty to relieve suffering (2009). 
 In a qualitative study exploring the lived experience of patients with AIDS, the majority 
of participants felt as though having family members, friends, pets, and caregivers around during 
the dying process would be an important contributor to creating a good death (Pierson et al., 
2002).  For some, a reason to request euthanasia or PAS offers an opportunity to say good-bye to 
their loved ones while remaining conscious (Georges et al., 2007), and patients who receive a 
lethal prescription are more likely to have the opportunity to say goodbye than those who do not 
participate in PAS (Smith, Goy, Harvath, & Ganzani, 2011).  “I think dying alone, not having 
anyone there to help make that crossing-over bearable, that would probably be the worst” 
(Pierson et al., p. 591, 2002).  This includes some desiring to have a religious figure present to 
perform last rites (Pierson et al., 2002), though patients who participate in PAS are less likely to 
engage in a spiritual ceremony than those who do not pursue PAS (Smith et al., 2011). 
Pierson et al. found that patients also preferred to be in their own home, and this location 
was correlated with a desire to have their loved ones present (2002).  Patients with ALS who 
participated in euthanasia or PAS most often died at home and with less anxiety, while patients 
who were receiving sedatives were more likely to die at a nursing home or hospice (Maessen et 
al., 2009).  In a systematic review of literature by Gamondi, Fusi-Schmidhauser, Oriani, Payne, 
and Preston, two sub-themes emerged when anticipating the final farewell: Patients who engaged 
in assisted dying were able to organize end-of-life rituals, and patients were allowed to choose 
the location of death (2019).  Family members rated the quality of the moment of death as higher 
in patients who engaged in PAS compared to those who did not (Smith et al., 2011). 
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Physician-assisted suicide promotes dying with dignity, and patients view PAS as more 
dignified than suicide (Nissim et al., 2009).  In patients who did use euthanasia or PAS, dignity 
in dying contributed to the patient having a better death experience, with 93% of relatives 
reporting that their loved ones died peacefully (Georges et al., 2007).  Physician-assisted suicide 
can significantly influence the quality of life and death in patients with terminal illnesses. 
 Patient-physician communication about end-of-life wishes. 
 Healthcare providers licensed to prescribe lethal prescriptions are the gateway to 
participating in physician-assisted suicide.  Therefore, open communication and building a 
positive relationship between patient and HCPs is central to ensuring patient input about their 
end-of-life wishes.  Having a good relationship with one’s HCP increases the patient’s feeling 
that they are receiving quality medical care (Pierson et al., 2002).  In addition, the HCP is 
responsible for ensuring patient understanding of every available end-of-life option, and 
miscommunications could result in missed opportunities to relieve patient suffering. 
 Timing. 
 As explained in the introduction, there is a complex process that takes place between a 
patient’s request for physician-assisted suicide and receiving the prescription.  Understanding the 
patient’s wishes as early as possible will help to guide the provider and ensure the patient 
receives care in a timely manner.  Many patients will disclose their wish for a hastened death to 
their loved ones earlier than to their healthcare provider.  Ganzini et al. found that ALS patients 
made explicit requests for PAS to their HCPs in the last month of life but had discussed 
considering PAS as an end-of-life option to their caregivers in previous months (2002).  A study 
by Georges et al. reports that 79% of patients expressed their wishes about end-of-life decisions 
to their partners (69%) or children (38%) before they became terminally ill, but only 33% of 
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patients spoke to their physician about their wishes prior to becoming terminally-ill (2007).  
Most explicit requests were made within three months of the patient’s death, with 29% of 
requests being made in the last week of life (Georges et al., 2007).  A study by Pasman et al. 
revealed that patients who make a request for PAS before reaching the terminal phase of illness 
will be refused, and many of these patients will then no longer discuss their desire for PAS with 
their healthcare provider, despite an ongoing wish to die (2013).    
 Patients in the early stages of Huntington’s disease worried that they would be physically 
unable to participate in PAS upon reaching the point in the dying process when they would 
desire it.  This caused them to wonder when they should formally document their wishes (Regan 
et al., 2017).  “If I am declining gradually, am I losing the ability to make those decisions?  So do 
I need to make that decision long before I am symptomatic in order to ensure that I don’t miss 
my opportunity? (Regan et al., p. 712, 2017). 
 Miscommunications. 
 Like any relationship, good communication creates a positive outcome; conversely, 
miscommunications add stress and contribute to negative outcomes.  Miscommunications 
between patient and healthcare providers about end-of-life wishes are common, often leading to 
unintended consequences.   
 Under-communicating is a form of miscommunicating and leads to a lack of knowledge.  
In a study by Silveira, DiPiero, Gerrity, and Feudtner interviewing 728 outpatients at various 
outpatient clinics in Oregon, only two-thirds of patients accurately identified that competent 
patients in Oregon can legally refuse life-saving or life-sustaining treatment (2000).  Knowledge 
of end-of-life options was found to be associated with a college education and being Caucasian 
(Silveira, DiPiero, Gerrity, & Feudtner, 2000)  Experiencing death or illness of a loved one was a 
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statistically significant association with better knowledge of end-of-life options.  One-third of 
participants had authored an advanced directive, but authoring an advanced directive was not a 
statistically significant association (Silveira et al., 2000).  In this study, patients’ knowledge was 
coming from sources other than their healthcare provider or was simply absent. 
 Miscommunications are common when an explicit request for aid-in-dying is made by 
the patient, and the healthcare provider’s response can negatively influence the patient’s 
experience.  Georges et al. found that 74% of patients found their HCP’s reaction to their request 
for euthanasia or PAS to be satisfactory, because they felt like their physician had insight (2007).  
However, 16% of patients were disappointed in the HCP’s response to their request, and 10% of 
patients were undecided due to the healthcare provider’s ambivalence (Georges et al., 2007).  
Pasman et al. explored the patient experience when requests for PAS were refused, with the 
reason for refusing being that the patient did not meet the criteria to participate in PAS or 
euthanasia (2013).  These patients reported still wanting aid-in-dying, even if it was not possible 
at that moment; they might not bring it up again if they believe that aid-in-dying was not possible 
for their condition or if the provider’s response appeared irrevocable (Pasman et al., 2013).  “I’ve 
told him several times, and once he said: ‘You mustn’t keep talking to me about euthanasia, 
because you know what I can do and what I can’t do, so forget about it’” (Pasman et al, p. 316, 
2013).  Several of the HCPs in this study were unaware that their patients still wished to die, and 
some even admitted to purposefully not bringing up the subject of aid-in-dying with the hope 
that the patient would not bring it up either (Pasman et al., 2013).  No appointments were made 
to evaluate the patient’s situation after the refusal, despite the possibility of the patient’s 
condition changing to meet the PAS criteria in the future (Pasman et al., 2013).   
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 A systematic review by Dees et al. found that the factors motivating patients to 
participate in euthanasia or physician-assisted suicide varied between the patient and the 
physician perspective, with little overlap.  The patients reported that their reasons for wanting to 
die included “pain, weakness, functional impairment, dependency, being a burden, hopelessness, 
indignity, intellectual deterioration, loss of oneself, loss of autonomy, and being tired of life” 
(Dees et al., p. 342, 2009).  The HCPs pointed to only general weakness, loss of dignity, and pain 
as patient motivations for PAS (Dees et al., 2009).    Healthcare providers may lack a clear 
understanding of the patient’s desire for PAS.    
 Stigma of talking about death. 
 Patients with advanced cancer report difficulties in discussing their impending death, 
noting that family and friends avoided the topic (Nissim et al., 2009).  Similarly, patients with 
Huntington’s disease reported little communication with their loved ones because of a cultural 
taboo of death (Regan et al., 2017).  This discomfort can even spread to conversations with their 
healthcare providers, “It’s the same with family and friends as well as medical professionals.  It’s 
kind of like people wanting to talk to you about it enough so that you feel heard, but not wishing 
to distress you by bringing it up at times when it feels uncomfortable” (Regan et al., p. 713, 
2017).  These participants felt as though they were left to manage their disease on their own, but 
the healthcare provider should be the one to guide the conversation about death (Regan et al., 
2017). 
 Good communication. 
 Patients dying from AIDS felt as though they had a good relationship with their HCP 
based on feeling like they were treated as a whole person and receiving quality care (Pierson et 
al., 2002).  According to their relatives, 74% of patients who died by euthanasia or PAS in the 
Autonomy and Physician-Assisted Suicide 28 
Netherlands were satisfied by how their HCP handled their request for assisted dying (Georges et 
al., 2007). 
 Patient autonomy. 
 Having access to PAS allows patients to maintain autonomy and a feeling of control until 
the very end of their life (Nissim et al., 2009).  Smith et al. found that the patient having control 
of his or her surroundings contributed to a better quality of dying (2011).  A desire to control 
one’s own death was the only psychological motivation for euthanasia or PAS that was shared by 
relatives, patients, and healthcare providers (Dees et al., 2010).  This includes being involved in 
treatment decisions and having the option to cease treatment whenever the patient desires 
(Pierson et al., 2002).  Patients with Huntington’s disease held the central belief that an 
individual has the right to autonomy, and assisted dying is a way of exercising this right (Regan 
et al., 2017).  A study by Gamondi et al. found that when a loved one’s desire for assisted dying 
was not fulfilled, family members felt as though the patient’s right to choose  PAS was 
disrespected (2019). 
 Subjectivity. 
 Suffering is subjective (Dees et al., 2010) as are the patients’ decisions on how and when 
to participate in the dying process.  “By having the choice to prolong or end suffering when there 
is no cure for certain illnesses, we as adult human beings should have the right to decide how 
much pain and suffering that we can endure.  Only we know that, not the doctors or the state or 
the government.  We should have that choice” (Pierson et al., p. 593, 2002).   Patients in the 
early stages of Huntington’s know that the suffering may eventually be too much, but each 
patient should be able choose that point for themselves (Regan et al., 2017). 
 Family experience. 
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 As mentioned previously, having one’s community present throughout the dying process 
is important to many (Pierson et al., 2002).  A systematic review of literature by Gamondi et al. 
reveals that family members who are involved in their loved one’s dying process have close 
bonds with the patient (2019).  Playing a role in the patient’s end-of-life care brings comfort to 
family members and contributes to family members feeling at peace with the patient’s decision 
(Gamondi, Fusi-Schmidhauser, Oriani, Payne, & Preston, 2019).  Smith et al. found no 
statistically significant differences in connectedness between patients and family in those who 
participated in PAS versus patients who did not (2011). 
 Witnessing the patient’s suffering worsen was a key motivator for families to embrace 
the patient’s request for assisted dying (Gamondi et al., 2019).  Some patients dying from AIDS 
believe that a ‘good’ death would include their families’ acceptance that they were going to die 
(Pierson et al., 2002). Patients with Huntington’s disease admit that they would delay dying if 
their families were not in agreement (Regan et al., 2017).  Gamondi et al. found that few families 
experienced regret about the patient’s cause of death when the patient did participate in 
euthanasia or PAS, though some family members wished the decision had been postponed 
(2019).   
 A ‘good’ death includes having a sense of resolution, having said good-bye, time to 
prepare, and peace with self and others (Pierson et al., 2002).  This preparedness represented 
positive components for the family’s bereavement and contributed to higher quality preparedness 
and symptom control ratings than those who did not die from assisted dying (Gamondi et al., 
2019).  
Summary of themes. 
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 As previously stated, significant gaps exist in the literature due to the nature of the topic.  
Physician-assisted suicide is limited to the few countries and states where it has been made legal; 
thus, the ability to openly study this topic is constrained.  The results from the abovementioned 
studies are not necessarily generalizable across cultures, religions, or healthcare delivery 
systems.  Additionally, as noted in the review of literature, suffering at the end-of-life is 
subjective, and therefore subject to subject variation cannot be measured.  Within subject 
variation also cannot be measured, since the subjects are no longer alive following the 
intervention.  Due to these limitations, studies about physician-assisted suicide are more likely to 
be qualitative versus quantitative, as with the research included in this paper. 
 For patients in the terminal phase of illness, end-of-life suffering is a personal, subjective 
experience.  Social stigma surrounds the topic of discussing one’s suffering and death; knowing 
this, the patient’s healthcare provider bears the responsibility of creating an open conversation 
about all end-of-life options with the patient.  Physical, emotional, and economic factors 
motivate terminally-ill patients to desire to participate in physician-assisted suicide, and the 
motivations can vary by diagnosis.  Physician-assisted suicide upholds the ethical principle of 
autonomy by allowing the patient to choose the timing, location, and context of their own death.  
Through avoiding suffering related to the dying process such as entering a persistent vegetative 
state, painful lingering, or loss of dignity, PAS contributes to a better quality of life and quality 
of death.  With physician-assisted suicide as an end-of-life option, patients can die on their own 
terms. 
Conceptual Framework 
 When discussing autonomy in Principles of Biomedical Ethics, Beauchamp and Childress 
report a misplaced criticism of respect for autonomy taking precedence over all moral 
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considerations (2001); others view autonomy as a cardinal moral value that should guide both 
politics and healthcare practices (Mackenzie, 2008).  Patient autonomy is central to the 
conversation about access to physician-assisted suicide as an end-of-life option, and relational 
autonomy theory provides a framework for the discussion of the patient experience with PAS in 
this paper.  In this section, “relational autonomy theory” will be used interchangeably with 
“relational autonomy.” 
 Relational autonomy theory is a rooted  feminist theory, “motivated by feminist concerns 
about the impacts of oppression and social injustice on women’s (and men’s) opportunities to 
lead self-governing lives” (Mackenzie, 2015, p.278), moving beyond the concept of “self-
governance” found in other theories of autonomy toward analyzing the social, political, and 
relational aspects of autonomy.   The goal of relational autonomy theory is to build social 
relationships and institutions that encourage individuals to lead self-governing lives (Mackenzie, 
2015).  Four key principles of relational autonomy theory and how it relates to the patient 
experience surrounding physician-assisted suicide will be explained in the subsequent 
paragraphs.  
 First, relational autonomy theory states that a person must have a series of self-reflective 
skills in order to achieve autonomy competence, “self-control and motivational decisiveness; 
emotional skills, such as the capacity to interpret and regulate one’s emotions; imaginative skills, 
required for understanding the implications of one’s decisions and envisaging alternative 
possible courses of action; and capacities to reflect critically on social norms and values” 
(Mackenzie, 2015, p. 286).  As explained in the review of literature, in seeking autonomy when 
considering physician assisted suicide, the terminally ill patient has been reflective on his or her 
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physical and emotional suffering, other courses of action such as simply withdrawing cares, and  
social values, for example, avoiding the subject of their own death due to social stigma. 
Secondly, relational autonomy theory is particularly relevant to medicine as it 
acknowledges a person’s vulnerability and dependence, in contrast to the popular belief that 
autonomy equals self-sufficiency (Mackenzie, 2015).  This is especially true during the terminal 
phase of illness, and the patient’s healthcare provider must recognize the patient’s vulnerable 
state.  As mentioned in the previous section, the provider’s role in promoting patient autonomy 
includes fostering a positive provider-patient relationship, communicating effectively about the 
patient’s end-of-life options, and being attentive to the patient’s wishes throughout the course of 
their disease.   
Thirdly, relational autonomy identifies that autonomous decision-making is sustained 
through significant social relationships, and one’s autonomy is not free from social influence 
(Mackenzie, 2015).  The literature reveals patients’ families embracing the patient’s request for 
PAS after witnessing the suffering brought on by the patient’s terminal stage of illness (Gamondi 
et al., 2019).  These social relationships can also be oppressive to the patient, corroding the 
patient’s sense of self-esteem (Mackenzie, 2015), such as patients dying from AIDS needing 
their families to accept their death in order for them to consider it a “good” death (Pierson et al., 
2002).  The patient’s healthcare provider also becomes a significant social relationship in the 
terminal phase of illness.  Regan et al. details the patients’ experiences of social stigma 
surrounding the conversation about their death, even when talking with their HCPs (2017).  
Patients are especially vulnerable to the attitudes and judgments of their HCP, which can aide in 
restricting their autonomy (Mackenzie, 2015).   
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Finally, relational autonomy considers the impact of societal oppression that restricts a 
person’s autonomy.  To live an autonomous life, all people from all social groups must have 
access to genuine opportunities and a range of options (Mackenzie, 2015).  Thus, the social 
distribution of autonomy must also be considered, for example, patient populations in some 
historically liberal U.S. states have access to physician-assisted suicide while those in other 
states do not.  Health and social policies have the capacity to both limit and increase patient 
autonomy. 
Conclusions, Implications, and Recommendations 
 The purpose of this paper is to explore the patient experience with physician-assisted 
suicide to determine if participants in PAS have more control over their end-of-life care.  This 
section will be organized by stating the author’s conclusions based on the review of literature, 
ending with implications for nursing and recommendations. 
Conclusions 
 Though limited to the states and countries where it has been legalized, physician-assisted 
suicide is an end-of-life option that allows patients to avoid parts of the physical and emotional 
suffering that accompany dying of a terminal illness such as cancer or a neurodegenerative 
disease.  Terminal illness is life-altering, and PAS contributes to a better quality of life and 
quality of death by allowing the patient to die on their own terms: deciding who is present, where 
and when their death will take place, and ultimately ending the process of painful and 
undignified lingering.  Suffering during the terminal phase of illness is subjective; each patient’s 
experience will be different, and the patient is the only one who can decide when he or she no 
longer wishes to suffer.  Healthcare providers play a lead role as a patient advocate by guiding 
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both the conversations surrounding the patient’s end-of-life wishes, informing the patient of all 
available end-of-life options, and assisting the patient carry out his or her death plan.   
Recommendations 
Further research should be performed surrounding the patient experience of physician-
assisted suicide in the United States and abroad.  This research will likely be limited to 
qualitative studies, which should delve deeper into the themes found in this paper:  patient 
motivations for participating in PAS, the influence of the patient-HCP relationship on the 
patient’s experience with PAS, and patient autonomy during the dying process.  In addition, 
other terminal illnesses should be included when studying PAS such as congestive heart failure, 
chronic obstructive pulmonary disorder, end-stage renal disease, Parkinson’s disease, or multiple 
sclerosis.   
Healthcare providers have a responsibility to uphold the patient’s autonomy.  Knowing 
that the dying experience is subjective, HCPs must adopt the role of student and learn the 
patient’s personal definitions of suffering and dying well.  Building a trusting relationship with 
the patient will assist in identifying terminally ill patients who may be interested in PAS as an 
end-of-life option.  All treatment options should be discussed frequently throughout the course of 
the patient’s illness, and the HCP should encourage the patient to choose the end-of-life option 
that best matches the patient’s values and desires.  If the HCP does not feel confident with 
having EOL discussions, the HCP should either invest in continuing education about all available 
EOL options or refer the patient to a different provider. 
In keeping with Relational Autonomy Theory and with the patient’s consent, the 
healthcare provider should include the patient’s significant social relationships when discussing 
end-of-life options with the patient.  This will provide a framework for the patient to maintain an 
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ongoing dialogue with his or her community and assist the patient’s loved ones in embracing the 
patient’s EOL decision.  Including these significant relationships will ultimately uphold 
autonomous decision making.   
In the U.S., physician-assisted suicide is illegal in 41 states as of 2019 (Villenueve, 
2019).  The majority of American terminally ill patients do not have access to PAS, an option 
that has been shown can contribute to better quality end-of-life.  Without permission to use 
physician-assisted suicide, patients are forced to endure end-of-life processes that are often 
drawn out and overwhelmed with suffering; this violates the ethical principle of autonomy: the 
patient’s right to request a specific treatment.  Thus, physician-assisted suicide should be 
legalized in all 50 states, giving every American access to all end-of-life options.   
Implications for Nursing 
 Nurses need to thoroughly analyze their own biases regarding physician-assisted suicide, 
educate themselves on the latest information on the subject, and promote open discussions about 
physician-assisted suicide amongst their peers.  An integrative literature review of American 
nurses’ opinions toward PAS found that the majority of nurses in four of the studies supported 
PAS primarily due to relieving the patient’s suffering, while nurses in six of the studies were 
against PAS primarily for religious and moral issues as well as the potential for the misuse or 
abuse of PAS (Pedersen & Tariman, 2017).  Nurses who do not support physician-assisted 
suicide should not be shamed for their opinions, but this does exhibit the propensity of healthcare 
providers to be unsupportive of a treatment based on their own values rather than those of the 
patient.  The nurses should support their patients whose values differ from their own by referring 
patient who are interested in PAS to a different nurse.   
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Pedersen and Tariman report that of the six studies finding nurses to be against PAS, 
three revealed that nurses might become supportive of PAS if they had more knowledge on the 
subject (2017).   Educating all nurses by adding curriculum or on the job training about 
physician-assisted suicide could garner support from nurses previously opposed to PAS.  If 
nurses remain unsupportive of physician-assisted suicide, particularly in states that legalize PAS, 
significant ethical dilemmas will be present while treating terminally ill patients. 
Summary 
According to the literature included in this paper, suffering and dying are profoundly 
personal experiences.  For patients with terminal illnesses such as advanced cancer and  
neurodegenerative diseases, physician-assisted suicide is an end-of-life option that allows the 
patient to avoid prolonged emotional and physical suffering, thereby contributing to a better 
quality end-of-life.  Working with patients in this terminal phase, medical professionals such as 
healthcare providers and nurses have the unique role of providing end-of-life care, upholding 
patient autonomy, and advocating for patients to be granted access to all available end-of-life 
options, including the legalization of PAS in all fifty states.  Though the concept of physician-
assisted suicide can make some healthcare professionals uncomfortable, the legalization of PAS 
in several countries and U.S. states makes this issue relevant.   The Hippocratic Oath reads, 
“Most especially must I tread with care in matters of life and death. If it is given me to save a 
life, all thanks. But it may also be within my power to take a life; this awesome responsibility 
must be faced with great humbleness and awareness of my own frailty” (Tyson, 2001).  
Physician-assisted suicide brings this tension to the forefront of the conversation: When to 
preserve life and when to let it go?  Based on the research in this paper, only the patient can 
answer this question. 
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Appendix 
REQUEST FOR MEDICATION TO END MY LIFE IN A HUMANE AND DIGNIFIED MANNER  
I, ______________________, am an adult of sound mind.  
I am suffering from _________, which my attending physician has determined is a 
terminal disease and which has been medically confirmed by a consulting physician.  
I have been fully informed of my diagnosis, prognosis, the nature of medication to be 
prescribed and potential associated risks, the expected result, and the feasible 
alternatives, including comfort care, hospice care and pain control.  
I request that my attending physician prescribe medication that will end my life in a 
humane and dignified manner.  
INITIAL ONE:  
______ I have informed my family of my decision and taken their opinions into 
consideration.  
______ I have decided not to inform my family of my decision. ______ I have no family 
to inform of my decision. 
I understand that I have the right to rescind this request at any time.  
I understand the full import of this request and I expect to die when I take the 
medication to be prescribed. I further understand that although most deaths occur 
within three hours, my death may take longer and my physician has counseled me 
about this possibility.  
I make this request voluntarily and without reservation, and I accept full moral 
responsibility for my actions.  
Signed: _______________ Dated: _______________  
DECLARATION OF WITNESSES  
We declare that the person signing this request: 
(a) Is personally known to us or has provided proof of identity; 
(b) Signed this request in our presence; 
(c) Appears to be of sound mind and not under duress, fraud or undue influence; (d) Is 
not a patient for whom either of us is attending physician. ______________Witness 
1/Date 
______________Witness 2/Date  
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NOTE: One witness shall not be a relative (by blood, marriage or adoption) of the 
person signing this request, shall not be entitled to any portion of the person’s estate 
upon death and shall not own, operate or be employed at a health care facility where 
the person is a patient or resident. If the patient is an inpatient at a health care facility, 
one of the witnesses shall be an individual designated by the facility.  
(Oregon Death with Dignity Act, 1994) 
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   Table 1 
   Database Search 
Date of 
Search 
Keywords Used Database/Source 
Used 
# of Hits 
Listed Reviewed Used 
09.01.19 Patient experience CINAHL/Ebsco 127,984   
09.01.19 Physician assisted suicide CINAHL/Ebsco 2,897   
09.01.19 “Patient experience” AND “physician 
assisted suicide” 
CINAHL/Ebsco 131 16 5 
09.11.19 Quality of life CINAHL/Ebsco 173,424   
09.11.19 Quality of death CINAHL/Ebsco 14,895   
09.11.19 “quality of life” AND “quality of death” 
AND “physician assisted suicide” 
CINAHL/Ebsco 59 15 5 
09.24.19 Physician assisted suicide The Cochrane 
Library 
2 2 1 





16 3 1 
09.24.19 Ganzani AND Silveira Incremental 
search of 
references 
1 1 1 
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as suffering is a 
requirement of 
due care and 
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request EAS  
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about suffering of 
patients with a 
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description of 
suffering of 
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actual request for 
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*Articles were 
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who reported the 
patient suffering, 
i.e.: patients, 
HCPs, or family 
*A third and 
fourth researcher 
helped analyze the 
qualitative data 
 
*Every study referred to 
suffering or “unbearable 
suffering” but no 
generally accepted 
definition 
*Four themes of 
suffering emerged: 
physical, psychological, 
existential, or spiritual, 
which all contributed 
equal numbers of 
motivations 
*Suffering in the context 
of dying is generated by 
factors undermining the 
quality of life 
*Themes in qualitative 
suffering: Caused by: 
pain, weakness, 
functional impairment, 
dependency, being a 
burden, hopelessness, 
indignity, intellectual 
deterioration, loss of 
autonomy, tired of life 
*Motivations for EAS 
differed between the 
patients, physicians, and 
family 
*Pt motivations: pain, 
Weakness, dependence 




*All forms of 
suffering are 
potentially 







HCPs to bring up 
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request EAS are 
complex 




is limited to 
countries where 





perspective is the 
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*Suffering involves 
the patient as a 
whole 
*Patients must be 
involved in 
suffering in order 
to meet criteria for 
PAS by physicians 
in Oregon and the 
Netherlands, yet it 
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economic and 
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and Brooklyn, NY. 
One rural setting as 
well: Mesa County, 
CO.   
*Physicians in 
those areas were 
randomly selected 
and asked to 









following a lit. 
search, pilot study, 
























“low” to “high” on 
a four point scale 
*Mean age: 66.5, leading 
cause of terminal illness: 
cancer (51.8%), heart 
disease (18%), and 
COPD (10.9%) 
*Pt’s with moderate or 
high care needs were 
significantly more likely 
than those with low care 
needs to report the cost 
of their illness was a 
moderate or great 
economic hardship 
(44.9% compared with 
35.3%, p=0.005), that 
10% of their household 
income was spent on 
healthcare costs other 
than insurance premiums 
(28% compared to 17%, 
p<0.001), and that they 
had to sell assets, take 
out a loan or mortgage, 
or obtain an additional 
job (16.3% compared to 
10.2%, p=0.004) 
*In patients requiring 
substantial assistance, 
14.9% had seriously 
thought about or 
discussed PAS compared 
to 8.2% of patients with 
few care needs, p=0.001 
*Terminally-ill 






other burdens  




but do not add 
cost 
*Important to 





*HCPs need to 
talk with patients 
AND families 
about cost  





*21% of referred 




*Cost of terminal 
illness is more than 
emotional 
*Terminal illness 
takes a toll on the 
entire family, 
particularly the 
financial health of 
the family 
*Sad that families 
have to take out 
additional 
loans/mortgages or 
get other jobs just 
to pay for the care 
of their loved one 
instead of spending 
time with the 
terminally ill 
*Study takes place 
in the USA 
*Difficult to obtain 
data on this topic 
d/t the patients 
dying or being 
mentally unable to 
participate 
*With PAS being 
illegal in most 
states, is the family 
unduly forced to 
carry a heavier 
economic burden? 
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*Family members 
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assisted dying 
*Witnessing the patient 
suffer motivated family 
members to agree with 
the pt’s request 
*Family members who 
shared the values of the 
patient saw the decision 
as the patient’s right 
*Positive emotions were 
experienced such as 
being at peace, accepting 
the patient’s choice, and 
having felt included 
*Few experienced regret 
*Family members 
perceived a fast decision-
making pace as being 
problematic 
*Some wished it had 
been postponed 
*Death rituals were 
intentional and planned 
*Family thought assisted 
dying contributed to the 
pt’s QOL 
*Families can be 
very involved in 
supporting pts 
interested in PAS 
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and Washington. 
Journal of Pain 
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Management, 
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terminal phase of 
their illness, 
particularly the 
final month of 
life 
*Terminally ill 
patients with ALS 
*N=50 family 
caregivers of 
patients with a 
confirmed 
diagnosis of ALS 
from Oregon and 
Washington who 
had died between 
1995-1999 
*Patients cared for 




clinic or Portland 
Veterans Affairs 
Medical Clinic or 
had participated in 








recruited by mail 
*Surveyed in 
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*An interview 
(median of 11 
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patients’ death and 
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survey (median of 
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interest in PAS 
*Caregiver knew patient 
for median of 34 years 
*16 (32%) explicitly 
discussed wanting PAS 
in the last month of life 
*Patients who requested 
PAS had frequent 
insomnia (p=0.003), pain 
(p=0.01), severe 
discomfort (p=0.03), and 
distress at being a burden 
(p=0.02) 
*No difference between 
those who did and did 
not want assisted suicide 
in the last month of life 
in prevalence of 
depression 
*The patient having 
indicated interest in 
assisted suicide in the 
previous study (OR: 
11.7, 95% CI: 1.1-130.7) 
and a hopelessness score 
of >9 on the Beck 
Hopelessness Scale (OR: 
12.5 (1.9-83.2) were 
predictors of pt 
continuing to request 
PAS 
*50% of patients initially 
interested in PAS had a 
persistent interest 
throughout the illness 
*Patients 
interested in PAS 
in the final 
month of life 







*Interest in PAS 
persists over 
time; important 





may help the pt 
avoid wanting 






before death (on 
patients) and 
after death (on 





Dignity Act was 
enacted in 1997; 
thus only four 
patients were 
eligible for PAS 
*Open 
communication 
between pt and 
provider about 









*Newly legal in 
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interview study in 
the Netherlands. 







and history of 
patient requests 
for EAS and the 
significance of 
EAS on the 
patient’s EOL 
*Studying patients 
who used EAS to 
end their lives 
 
*Interviewed most 












*Mean period of 
time between the 










sampling of 167  
physicians with 










on pt’s illness, 
motivations for 
EAS, end of the 













*85% had cancer, 15% 
had other diseases, 
mostly neurologic such 
as ALS 
*79% of pts had voiced 
their wishes prior to 
being terminally ill 
*67% of wishes directed 
at unbearable suffering 
and heavy dependence on 
others 
*84%: explicit requests 
made w/in 3 mos. of 
death 
*74% satisfied with how 
the physician dealt with 
the request 
*Patients <68yrs were 
concerned about missing 
an important life event 
(p=0.031) 
*92% of relatives 
believed EAS 
contributed to the 
patient’s quality of the 
end-of-life by avoiding 
further suffering (37%), 
respecting the pt’s wish 
(29%), dignity would be 
preserved (18%), ending 
current suffering (16%) 
*23% thought EAS came 
too late, causing more 
pain/suffering 
*Close relatives 
of the dying 
patient should be 















life events that 
they want to 
attend  
*Taking time to 
sort through the 
patient’s request 
may prolong pt 
suffering 
*Retrospective 










and pts feeling like 
a burden; they may 
not even feel like 





are part of the 
patient, when 
thinking about or 
planning the 
patient’s dying 








suffering in certain 
patients 
*Thinking about 
EAS is different 
than making an 
explicit request 
*EAS is respecting 
the patient’s wishes 
and feeling in 
control 
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To explore and 
describe attitudes 
and wishes for 
euthanasia/PAS 
in a group of 
patients with 
advanced cancer 




cancers: lung (n=2), 
prostate (n=5), GI 









mos. per MD 
*Convenience 
sample on the 
Palliative Medicine 
Unit, Department 






time of interview: 3 





guide with 8 
issues + sub 
questions 
*RN did not work 
at the hospital 
*One, 45 minute 
face to face 
interview 
*Euthanasia/PAS 
defined to patients 




















*Positive attitude toward 
Euthanasia/PAS: Fear of 
future pain and/or poor 
quality of life; right to 
choose when suffering 
should end 
*Negative attitude: 
Religious and ethical 
arguments such as the 
wrongdoing of taking life 
*Possibility of wishing 
for euthanasia/PAS; none 
of the patients wished for 
euthanasia/PAS at the 
time of the interview, 
always future oriented 
*Factors influencing 
wishes for 
euthanasia/PAS: Fear of 
future pain, worries 
about future poor QOL, 
worries about future lack 
of hope 
*Experiences of previous 
pain caused fear of future 
pain attacks in the future 
*Will to live decreased 
with unbearable pain; 
wish to die disappeared 
with pain alleviation 
*Most patients expressed 
hope for the future, such 











*Pain is an 
indicator of QOL 
if cancer patients 
*More research 









*Validity may be 
limited due to 





is illegal in 
Norway; patients 
may not have 
answered 
honestly 















because there is not 
a universal timeline 
or course of disease 
*Whether or not 
PAS/Euthanasia is 
legal in the study’s 
country could 
influence results 
*Hope for the 
future influences 
the decision to 
desire to participate 
in PAS; can hope 
be cultivated? 
*A wish for PAS is 
different than a 
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life practices in 
patients with 
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sclerosis (ALS)  
 
*University 




center for ALS 
patients 
 
*Patients who died 
between January 
2000 – June 2005 
 
*Involved patient’s 
physician (N=204)  
and informal 
caregiver (N=209) 




























compared to the 
questionnaire 








*35 (16.8%) patients 
participated in 
euthanasia/PAS from 
2000-2005, not a 
significant change 
previous data 
*PAS/EAD patients had 
higher level of education 
(p=0.03), did not think 
religion was important 
(p=0.04) 





quality of care for 
patients with PAS/EAD 
and other patients 
*Reasons reported by 
informal caregivers for 
PAS/EAD: fear of 
choking, no chance of 
improvement, loss of 
dignity, dependence on 
others, fatigue.  
Infrequently mentioned: 
pain, feeling like a 
burden 
*PAS/EAD: More likely 
to die at home (p=0.007) 
vs hospice /nursing home 
*All deaths considered 





not increase (not 
a slippery slope) 
*Patients were 
able to be at 
home 





















caregiver, not the 




PAS seem to be 
consistent; perhaps 
pain wasn’t an 
issue because it 
was ALS versus 
cancer or other 
terminal diagnoses 
*Interesting that 





*Dying at home 
versus going into a 
SNF: might also be 
specific to ALS 
*Unable to ask the 
patient how his/her 
experience was; 
data is limited to 
patient proxies  
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*Mean age: 61 
*19 participants died 
during study; mean final 
interview timeline: 3 
months before death  
Three categories: 
*DHD as a hypothetical 
exit plan: Common and 
persistent (89% pts), 
future plan when all else 
had failed, provided 
reassurance of autonomy 
until the end, enhanced 
ability to tolerate present, 
9 patients wished PAS 
were legal and is morally 
justifiable to relieve 
suffering, rarely 
discussed with others 
*DHD as an expression 
of despair: Pts feel 
emotionally trapped in 
despair and hopelessness, 
experienced by all pts but 
transient, for a few days. 
Often triggered by pain 
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Emerged in final weeks, 
recognition that death is 
imminent, welcomed, 
refused treatments, 
reached “limit”, difficult 
to discuss dying with 
family and friends 
*Being able to 
hasten death 
allows patients to 
feel in control in 
all stages of 
terminal illness, 
not just at the 
end 
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not a crisis 










could help them 











could be biased 
*Access to PAS 
helps patients bear 
current suffering, 
PAS being legal 
may enhance QOL 
in the present, even 
if pts do not 
participate in PAS 
*PAS being illegal 
prolongs suffering 
and limits pt 
autonomy 
*Nonmaleficence 
is potentially being 
violated by forcing 
patients to suffer 
who wish to hasten 
their death 
*Rare to have data 
about the patient 
experience in the 
final stage of 
illness 
*Not talking about 
death with HCPs or 





may give the pt 
“permission” to 
talk about EOL 
preferences  
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both patient and 
physician about 
the situation 
when EAS is 
refused 
*Patients who had 
been refused EAS 
or a relative of a 
patient who had 
been refused and 
died prior to study 
 
*N = 12, 3 of these 
were relatives of a 
patient who had 
died after being 
refused, 




consented to their 
physician being 
interviewed (N=11; 
one patient had two 
physicians), 

















asking if the 
patient (or relative 
of a decedent) had 
been refused EAS 
in the last 3 years  
*Single interview, 
patient: 60-120 
min., MD: 30-60 
min 
*Topic list: 














were involved in 
coding 
*None of the pts were in 
disease terminal phase 
*All MDs had >5 years 
of experience, most had 
performed EAS 
 
*MDs all denied request 
because lawful criteria 
had not been met; 6/11 
had doubts that the pt’s 
suffering was unbearable, 
5/11 thought there were 
treatment alternatives, 
3/11, thought pt was not 
sincere because the pt 
only mentioned it once 
 
*All 9 pts and 3 relatives: 
wish to die remained 
after being denied, even 
after alt. treatments; most 
thought no longer an 
option after being refused 
 
*None decided to switch 
physicians after being 
refused 
 
*Several cases, the MD 
had a different 
perspective than the pt 
















*A pt no longer 
mentioning their 
wish to die does 
not mean that it 
does not exist 
 














a HCP is supposed 
to measure it to 
fulfill the legal 
criteria?  This 
seems unfair to 





between pts and 
MD about EOL 
care are common 




death with patients 
may open up 
conversations 
about specific EOL 
options   
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J., & Patrick, D. 
(2002). A good 
death: A 
qualitative study 
of patients with 
advanced AIDS. 












consider a “bad” 
or “good” death  
Patients diagnosed 
with an AIDS-
defining illness and 
a CD4 count 
<100cells/ml, 
English speaking, 
no diagnosis of 
dementia 
 








in the state of 
Washington, USA 
 
Sample size was 











Face to face 
interview in a 
quiet setting with 
only the 
interviewer and 





open and selective 
coding was used 










discussed, and a 
third investigator 
acted as an 
arbitrator if an 
agreement could 
not be reached 
*15 domains were 
identified as defining a 
“good”/”bad” death 
*The most mentioned 
domain influencing a 
“good death” was 
symptom control; 
absence of pain was the 
most stated concern, and 
degree of pain correlated 
with a death being 
labeled as “bad” 
*The second domain was 
“quality of life,” 
specifically avoiding a 
prolonged dying 
experience, fear of 
becoming a “vegetable” 
or living on machines 
*PAS was the tenth most 
common domain 
contributing to a good 
death, with several 
patients stating that PAS 
would ensure the “good” 
death that they desired 







wishes with their 





*PAS may play 
an important role 















stage of the 
dying process 










plays an important 









on the stage of 
death   
 
*Nice that the 
interview focused 
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11 Regan, L, Preston, 
N., Eccles, F., & 
Simpson, J. 
(2017). The views 
of adults with 
Huntington’s 











To explore the 
perspective of 







*People who had a 
diagnosis of 
Huntington’s 
disease  or tested 
positive for the 
mutant gene  
 
*N=7; 5 women, 2 
men 
 
*Median age: 35 
years, pre-
symptomatic or in 


















median length: 47 
minutes. 5 via 





transcribed, then  









Four identified themes:  
1) Autonomy: Assisted 
dying as a way to take 
control as well as an act 
of kindness.  A point 
would be reached when 
life would no longer be 
meaningful, each person 
should choose that point 
for themselves 
2) Huntington’s disease 
emphasizes death: 
Suffering was more 
about loss of self than 
pain; many witnessed 
their relatives die from 
Huntington’s, which 
influenced views on PAS 
3) Dilemmas in decision-
making: No cure for 
Huntington’s; PAS is an 
imperfect solution. Might 
be too physically/ 
congnitively impaired to 
participate in PAS. 
Illegal in Britain, so 
would have to be well 
enough to travel  
4) Absence of explicit 
conversation about death: 
Difficult topic of 
conversation, often 
avoided with family and 





feelings r/t death 
from the very 
beginning of a 
diagnosis such as 
Huntington’s; 
the patient is 
already thinking 
about it. Patients 
may otherwise 
not know EOL 
options 








*Early in the 
disease process, 












*Point at which life 
is not meaningful is 
subjective 
*Suffering was less 
about pain and 
more about loss of 
self; similar to ALS 
study 
*PAS is not a 
solution or a cure, 
just a way to ease 
suffering 
*Huntington’s 
disease process is 
long and drawn 
out; likely will not 
qualify as 
terminally ill (<6 
mo), likely would 
not qualify for PAS 
(unable to 
physically/mentally 
meet criteria once 
they are deemed 
terminally ill) 
*Illegal in many 
states, thus forcing 
people to have to 
be well-enough to 
relocate  
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options at the end-









are aware of 4 









and the doctrine 
of double effect 
*Outpatients going 








*4 primary care 
sites around the 
state of Oregon, 
USA:  Internal 




Portland; 3 family 
practice/internal 

























of a hypothetical 











or terminal illness 




*69% understood that 
competent pts can refuse 
treatment 
*46% identified that pts 
can legally withdraw care 
*23% identified PAS as 
an option in Oregon for 
competent pts with 
terminal illness 
*32% reported that 
euthanasia was illegal 
*41% recognized double 
effect as legal (giving 
pain meds knowing that 
it could end the patient’s 
life) 
*64% of respondents 
who knew PAS was legal 
also thought that 
euthanasia was legal 
*89% thought survey 
was clearly worded 




experience of death of 
loved ones (p<0.01) 
*Personal experience 
with illness and 
authoring an advanced 
directive were not 
significantly associated 
with better knowledge 
*Misunderstandi
ng of EOL 
options; 
important to 












EOL cares with a 
family member 
is one of the 
main ways to 















after the 1997 
referendum 
confirming the 
Death with Dignity 
Act; even with all 
of the public 
discussion 
surrounding PAS, 




shows that EOL is 




discuss with HCPs 
*How to best 
educate the public 
about EOL 
options? 
*Should not be the 
case that people are 
more educated 
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13 Smith, K., Goy, 
E., Harvath, T., & 
Ganzani, L. 
(2011). Quality of 













To determine if 
there was a 
difference in the 










but did not 
receive a lethal 
prescription, and 
patients who did 
not participate in 
PAS 
*Family members 
of terminally ill 
patients who 
participated in PAS 
(N=52), patients 
who requested but 
did not receive PAS 
(N=32), and 
patients who did 
not partake in PAS 
(N=63) 
*Convenience 
sample; recruited in 
NW Oregon from 2 











*Used a validated 
instrument: 
Quality of Death 






















*PAS patients had more 
control over their 
surroundings and ability 
to feed self than the other 
two groups (p <0.01) and 
control of bladder/bowel 
and energy than the 
group who requested but 
did not receive PAS 
(p<0.05) 
*No significant items in 
the connectedness + 
transcendence domains  
*Those who received a 
prescription were more 
likely to say good-bye to 
loved ones (p = 0.003) 
and less likely to engage 
in a spiritual ceremony (p 
= 0.002) than those who 
did not pursue PAS  
*No significant 
differences between 
groups were found in 
family member’s 
perception of overall 
quality of life in the week 
before death 
*Family members rated 
the quality of the 
moment of death higher 
in PAS patients (p 
<0.001) 
*Better quality 





being able to 
prepare for death 
*By preparing, 
PAS patients are 
able to say good-
bye to loved 
ones 




*PAS should be 
legal in all states, 
allowing the 













*Able to avoid a 
“state worse than 
death” by avoiding 
physical suffering 
using PAS 
*Dying is a 
subjective 
experience; unable 





when a patient is 
terminally ill to 
allow the patient to 
choose what is best 
for them 
*PAS meets the 
patient’s desire to 
control their death 
experience and 
avoid suffering 
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